Markets:

Overview

News

Currencies

International

Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.260 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session ↗

July 27, 2022

Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.

Via Benzinga

Sonnet BioTherapeutics Announces Clinical Trial of SON-080 in Patients with Persistent Chemotherapy-Induced Peripheral Neuropathy

July 22, 2022

Via ACCESSWIRE

Sonnet BioTherapeutics Announces Clinical Trial of SON-080 in Patients with Persistent Chemotherapy-Induced Peripheral Neuropathy

July 22, 2022

PRINCETON, NJ / ACCESSWIRE / July 22, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that a Phase...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers

July 21, 2022

Via ACCESSWIRE

Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers

July 21, 2022

PRINCETON, NJ / ACCESSWIRE / July 21, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that a second...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

44 Stocks Moving In Friday's Mid-Day Session ↗

June 10, 2022

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Via Benzinga

Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate ↗

March 16, 2022

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

69 Biggest Movers From Yesterday ↗

June 10, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.

Via Benzinga

Mid-Afternoon Market Update: Skillsoft Falls After Q1 Results; Applied UV Shares Spike Higher ↗

June 09, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Thursday.

Via Benzinga

Mid-Day Market Update: Dow Drops 150 Points; Bluejay Diagnostics Shares Jump ↗

June 09, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping 150 points on Thursday.

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

June 09, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 09, 2022

Via Benzinga

Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition

June 09, 2022

PRINCETON, NJ / ACCESSWIRE / June 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs,...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum

June 02, 2022

PRINCETON, NJ / ACCESSWIRE / June 2, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs,...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update

May 10, 2022

- IND for SON-1010 cleared by FDA with first patient dosed in trial for advanced solid tumors - SON-080 on track to begin clinical studies by mid-2022 - Preclinical data for SON-1010, SON-1210, and...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 13, 2022

Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors

April 13, 2022

PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that dosing has...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting

April 08, 2022

PRINCETON, NJ / ACCESSWIRE / April 8, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from...

From Sonnet BioTherapeutics, Inc.

Via AccessWire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 08, 2022

Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

16 Stocks Moving in Friday's Pre-Market Session ↗

April 08, 2022

Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 18, 2022

Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 27.8% to $1.77 during Friday's regular session. The current volume of 149.1K shares is 551.4% of...

Via Benzinga

58 Biggest Movers From Friday ↗

March 21, 2022

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)...

Via Benzinga

45 Stocks Moving In Friday's Mid-Day Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 18, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock increased by 15.5% to $3.5 during Friday's pre-market session. The company's market cap stands at $15.6 million....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 18, 2022

Good morning, trader! Let's start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

25 Stocks Moving in Friday's Pre-Market Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) shares rose 23.7% to $11.90 in pre-market trading...

Via Benzinga

22 Stocks Moving in Thursday's Pre-Market Session ↗

March 17, 2022

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 results. Orphazyme A/S (NASDAQ: ORPH) shares rose 35.1% to $0....

Via Benzinga

80 Biggest Movers From Yesterday ↗

March 17, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares gained 86.7% to close at $0.5150 on Wednesday after the company announced FDA clearance of its IND for SON-...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 16, 2022

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today